Literature DB >> 2898535

Meiotic recombination in the beta globin gene cluster causing an error in prenatal diagnosis of beta thalassaemia.

C Camaschella1, A Serra, G Saglio, M T Bertero, U Mazza, S Terzoli, B Brambati, L Cremonesi, M Travi, M Ferrari.   

Abstract

In the course of a prenatal diagnosis for beta thalassaemia by linkage analysis of restriction fragment length polymorphisms, a homozygous beta thalassaemia fetus was misdiagnosed as beta thalassaemia trait. Extensive studies of the polymorphic sites within the beta globin gene cluster in all the members of the family resulted in the conclusion that the paternal chromosome 11 of the newborn was different from that expected. Paternity was confirmed by HLA typing and blood group studies. The analysis of another polymorphic locus on chromosome 11 within the family was in agreement with the possibility of a crossing over between the two paternal chromosomes in a region 5' to the beta gene, previously indicated to contain a 'hot spot' area for recombination. This report underlines the risk of performing prenatal diagnosis using restriction polymorphisms 5' to the beta gene.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898535      PMCID: PMC1050455          DOI: 10.1136/jmg.25.5.307

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  19 in total

Review 1.  Prenatal diagnosis of human genome variation.

Authors:  D M Kurnit; H Hoehn
Journal:  Annu Rev Genet       Date:  1979       Impact factor: 16.830

2.  A new DNA polymorphism for prenatal diagnosis of beta-thalassaemia in Mediterranean populations.

Authors:  J S Wainscoat; J M Old; S L Thein; D J Weatherall
Journal:  Lancet       Date:  1984-12-08       Impact factor: 79.321

3.  Different 3' end points of deletions causing delta beta-thalassemia and hereditary persistence of fetal hemoglobin: implications for the control of gamma-globin gene expression in man.

Authors:  D Tuan; E Feingold; M Newman; S M Weissman; B G Forget
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  Nonrandom association of polymorphic restriction sites in the beta-globin gene cluster.

Authors:  S E Antonarakis; C D Boehm; P J Giardina; H H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

5.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

6.  Prenatal diagnosis of sickle-cell anemia in the first trimester of pregnancy.

Authors:  M Goossens; Y Dumez; L Kaplan; M Lupker; C Chabret; R Henrion; J Rosa
Journal:  N Engl J Med       Date:  1983-10-06       Impact factor: 91.245

7.  Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation.

Authors:  Y W Kan; A M Dozy
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

8.  Ha-ras hypervariable alleles in myelodysplasia.

Authors:  S L Thein; D G Oscier; J Flint; J S Wainscoat
Journal:  Nature       Date:  1986 May 1-7       Impact factor: 49.962

9.  Antenatal diagnosis of haemoglobinopathies by improved method of isoelectric focusing of haemoglobins.

Authors:  M Ferrari; A Crema; A Cantù-Rajnoldi; S Pietri; M Travi; B Brambati; S Ottolenghi
Journal:  Br J Haematol       Date:  1984-06       Impact factor: 6.998

10.  Prenatal diagnosis using DNA polymorphisms. Report on 95 pregnancies at risk for sickle-cell disease or beta-thalassemia.

Authors:  C D Boehm; S E Antonarakis; J A Phillips; G Stetten; H H Kazazian
Journal:  N Engl J Med       Date:  1983-05-05       Impact factor: 91.245

View more
  1 in total

1.  Meiotic recombination in an Irish family with beta-thalassaemia.

Authors:  G W Hall; M Sampietro; R Barnetson; J Fitzgerald; S McCann; S L Thein
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.